Portfolio Company · Operating Co.

Amplifyer Bio

Healthcare, Medicines

backed byPillar VC

CurrentHealthcare, Medicines

Amplifyer Bio

a portfolio company of

Pillar VC

Status on record: Current

Investment year: 2023

PE Firm Index

Who owns Amplifyer Bio?

Amplifyer Bio is listed as a current portfolio company of Pillar VC on Pillar VC's own portfolio page. Pillar VC has owned Amplifyer Bio since 2023, per Pillar VC's portfolio page.

Company Snapshot

Amplifyer Bio is a Healthcare, Medicines company. Its owner on record, Pillar VC, is a firm. Pillar VC lists at least 78 companies in the index, 13 of them in Healthcare, Medicines.

SectorHealthcare, Medicines

Parent PE firmPillar VC

Ownership statusCurrent

WebsiteNot on record

About the owner

Pillar VC

Companies in the index: At least 78

Early-stage venture capital firm based in Boston.

Read the Pillar VC profile

Questions about Amplifyer Bio

Who owns Amplifyer Bio?

Amplifyer Bio is listed as a current portfolio company of Pillar VC on Pillar VC's own portfolio page. Pillar VC has owned Amplifyer Bio since 2023, per Pillar VC's portfolio page.

What sector is Amplifyer Bio in?

Amplifyer Bio is in Healthcare, Medicines. Classified from the owner's portfolio label.

What else does Pillar VC own in Healthcare, Medicines?

Pillar VC lists 12 other Healthcare, Medicines companies in the index, including Adaptilens, Amber Bio, Drosera Bio, Euler Bio and Metri.

Sources

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Amplifyer Bio and does not provide investment advice.

Other portfolio companies of Pillar VC

6 of 77 shown

Abridge

Advanced Computing, Healthcare

AceLab

Enterprise Intelligence

Decentralized Systems

Amber Bio

Medicines, Synthetic Biology

See the full Pillar VC portfolio.

Other Healthcare, Medicines companies held by Pillar VC

Adaptilens Amber Bio Drosera Bio

Euler Bio Metri Mirian

Other Healthcare, Medicines portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Pillar VC

Status: Current

Investment year: 2023

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.